Pharnext SA
Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of bac… Read more
Market Cap & Net Worth: Pharnext SA (PNEXF)
Pharnext SA (PINK:PNEXF) has a market capitalization of $3.99 Billion ($3.99 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37857 globally and #12335 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharnext SA's stock price $1.00 by its total outstanding shares 3989329920 (3.99 Billion).
Pharnext SA Market Cap History: 2019 to 2024
Pharnext SA's market capitalization history from 2019 to 2024. Data shows growth from $3.99 Billion to $3.99 Billion (0.00% CAGR).
Pharnext SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharnext SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
398932.99x
Pharnext SA's market cap is 398932.99 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.99 Billion | $252.77K | -$23.31 Million | 15782.26x | N/A |
| 2020 | $3.99 Billion | $39.83K | -$21.56 Million | 100158.92x | N/A |
| 2021 | $3.99 Billion | $84.78K | -$30.62 Million | 47052.31x | N/A |
| 2022 | $3.99 Billion | $7.22K | -$28.44 Million | 552156.39x | N/A |
| 2023 | $3.99 Billion | $10.00K | -$27.52 Million | 398932.99x | N/A |
Competitor Companies of PNEXF by Market Capitalization
Companies near Pharnext SA in the global market cap rankings as of March 19, 2026.
Key companies related to Pharnext SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Pharnext SA Historical Marketcap From 2019 to 2024
Between 2019 and today, Pharnext SA's market cap moved from $3.99 Billion to $ 3.99 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $3.99 Billion | 0.00% |
| 2023 | $3.99 Billion | 0.00% |
| 2022 | $3.99 Billion | 0.00% |
| 2021 | $3.99 Billion | 0.00% |
| 2020 | $3.99 Billion | 0.00% |
| 2019 | $3.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of Pharnext SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.99 Billion USD |
| MoneyControl | $3.99 Billion USD |
| MarketWatch | $3.99 Billion USD |
| marketcap.company | $3.99 Billion USD |
| Reuters | $3.99 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.